Life Science IPO Summit: Preparing for the Market Rebound
San Francisco, CA
Event summary
Cooley is proud to sponsor the Life Science IPO Summit at the Nasdaq Entrepreneurial Center in San Francisco. With the initial public offering market predicted to rebound within the next year, the summit is a must-attend event for executives seeking to navigate the current market and start positioning their companies for future success.
At the summit, a carefully curated group of executives from life sciences companies that have recently gone public and venture capital investors shared their firsthand experience across multiple sessions, including a capital markets update, a venture capital and private equity perspectives panel, a company readiness panel, and a board composition and corporate governance panel.
Featured agenda item
Venture Capital and Private Equity Perspectives
Cooley partner Denny Won moderated this panel, which featured a discussion among venture capital and private equity investors on IPO readiness in the current market.
For more information, please email Andrew Gentilucci.
Related contacts
This content is provided for general informational purposes only, and your access or use of the content does not create an attorney-client relationship between you or your organization and Cooley LLP, Cooley (UK) LLP, or any other affiliated practice or entity (collectively referred to as “Cooley”). By accessing this content, you agree that the information provided does not constitute legal or other professional advice. This content is not a substitute for obtaining legal advice from a qualified attorney licensed in your jurisdiction and you should not act or refrain from acting based on this content. This content may be changed without notice. It is not guaranteed to be complete, correct or up to date, and it may not reflect the most current legal developments. Prior results do not guarantee a similar outcome. Do not send any confidential information to Cooley, as we do not have any duty to keep any information you provide to us confidential. This content may be considered Attorney Advertising and is subject to our legal notices.